We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Danaher (DHR) Beats on Q1 Earnings & Revenues, Guides Up
Read MoreHide Full Article
Danaher Corporation (DHR - Free Report) is a global conglomerate that designs, manufactures and markets diverse lines of professional, medical, industrial, commercial and consumer products.
DHR’s tried and tested business model – the Danaher Business System (‘DBS’) – has proved to be the fundamental growth driver, fueling revenue, margins, cash flow and earnings improvement. Furthermore, DHR’s previously completed acquisitions have also been driving its top-line growth significantly. Furthermore, positive industry trends like new regulations from the Chinese Food and Drug Administration are expected to act as tailwinds.
Despite these positives, DHR has faced stunted organic revenue growth in its dental segment, mainly attributable to weakness in higher-margin traditional consumables business. Moreover, softness in industrial markets in China, North America, Latin America and the Middle East has been severely impacting the company’s business.
DHR consistently beat earnings in the trailing four quarters, with an average positive surprise of 2.8%.
Revenue: Revenues of $4,695.4 million topped the Zacks Consensus Estimate of $4,547 million.
Key Stats: Concurrent with the earnings release, DHR raised its full-year 2018 guidance. It now expects adjusted net earnings per share to lie in the range of $4.38 to $4.45, compared to the earlier guided range of $4.25 to $4.35. Overall, the company reported impressive key metrics largely driven by its effective business model, the DBS, which focuses on three critical areas -- quality, delivery, and cost & innovation.
Stock Price: DHR shares were inactive following the release. It would be interesting to see how the market reacts to the results during the trading session today.
Check back later for our full write up on this DHR earnings report later!
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
Image: Bigstock
Danaher (DHR) Beats on Q1 Earnings & Revenues, Guides Up
Danaher Corporation (DHR - Free Report) is a global conglomerate that designs, manufactures and markets diverse lines of professional, medical, industrial, commercial and consumer products.
DHR’s tried and tested business model – the Danaher Business System (‘DBS’) – has proved to be the fundamental growth driver, fueling revenue, margins, cash flow and earnings improvement. Furthermore, DHR’s previously completed acquisitions have also been driving its top-line growth significantly. Furthermore, positive industry trends like new regulations from the Chinese Food and Drug Administration are expected to act as tailwinds.
Despite these positives, DHR has faced stunted organic revenue growth in its dental segment, mainly attributable to weakness in higher-margin traditional consumables business. Moreover, softness in industrial markets in China, North America, Latin America and the Middle East has been severely impacting the company’s business.
DHR consistently beat earnings in the trailing four quarters, with an average positive surprise of 2.8%.
Currently, DHR has a Zacks Rank #2 (Buy) but that could change following its first quarter 2018 earnings report which has just released. You can see the complete list of today’s Zacks #1(Strong Buy) Rank stocks here.
We have highlighted some of the key details from the just-released announcement below:
Earnings: Adjusted earnings per share for the first-quarter 2018 came in at 99 cents, which beat the Zacks Consensus Estimate of 93 cents.
Danaher Corporation Price and EPS Surprise
Danaher Corporation Price and EPS Surprise | Danaher Corporation Quote
Revenue: Revenues of $4,695.4 million topped the Zacks Consensus Estimate of $4,547 million.
Key Stats: Concurrent with the earnings release, DHR raised its full-year 2018 guidance. It now expects adjusted net earnings per share to lie in the range of $4.38 to $4.45, compared to the earlier guided range of $4.25 to $4.35. Overall, the company reported impressive key metrics largely driven by its effective business model, the DBS, which focuses on three critical areas -- quality, delivery, and cost & innovation.
Stock Price: DHR shares were inactive following the release. It would be interesting to see how the market reacts to the results during the trading session today.
Check back later for our full write up on this DHR earnings report later!
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>